Abstract
Since March 1972, etomidate has been taken on clinical trial. Metabolism occurs quickly. Up to now, there was no evidence of histamine release or immunodepressant effect either in biochemical investigations or in clinical tests. A final conclusion, however, should only be made after many years of clinical experience. As shown in the EEG, the deep stages of narcosis are similar to those of barbiturates. The absence of analgesia and frequency of myocloni during etomidate narcosis make us assume that, unlike with barbiturates, there is no inhibition of the thalamic (diencephalic) region or of any subthalamic structures.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1977 Springer Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Doenicke, A. (1977). Etomidate as “A New Drug in Intravenous Anaesthesia” (Conclusion). In: Doenicke, A. (eds) Etomidate. Anaesthesiology and Resuscitation / Anaesthesiologie und Wiederbelebung / Anesthésiologie et Réanimation, vol 106. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-66787-9_18
Download citation
DOI: https://doi.org/10.1007/978-3-642-66787-9_18
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-08485-3
Online ISBN: 978-3-642-66787-9
eBook Packages: Springer Book Archive